Smartkarma North Asia Weekly: POTUS Order, Kanzhun, Angelalign, & 3 Children Policy in China
In this edition of the Smartkarma North Asia Weekly, it summarizes some of the top insights on Smartkarma in the past week covering Japan, HK...
262 Views
China: 3rd Child Policy and 3 Beneficiaries
I take a brief look at the China's past child birth policy changes and three beneficiaries of the exposure to the new birth policy.
252 Views
Suzhou Basecare Medical IPO: Trading Debut
Basecare priced its IPO at HK$27.36 and closed 14% up at HK$31.20 in the grey market. Our DCF sensitivity analysis shows that the IPO price is...
370 Views
Basecare Medical (贝康医疗) IPO Trading - Poised for a Strong Debut
Basecare Medical (2170 HK) raised about US$235m at HK$27.36 per share, the top-end of its IPO price range. The company is a genetic testing...
414 Views
ECM Weekly (31 January 2021) - Kuaishou, Basecare Med, MicroPort Cardioflow, Cloopen
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
511 Views